179 related articles for article (PubMed ID: 18326820)
1. Alpha4beta1 integrin and 190-kDa CD44v constitute a cell surface docking complex for gelatinase B/MMP-9 in chronic leukemic but not in normal B cells.
Redondo-Muñoz J; Ugarte-Berzal E; García-Marco JA; del Cerro MH; Van den Steen PE; Opdenakker G; Terol MJ; García-Pardo A
Blood; 2008 Jul; 112(1):169-78. PubMed ID: 18326820
[TBL] [Abstract][Full Text] [Related]
2. A 17-residue sequence from the matrix metalloproteinase-9 (MMP-9) hemopexin domain binds α4β1 integrin and inhibits MMP-9-induced functions in chronic lymphocytic leukemia B cells.
Ugarte-Berzal E; Bailón E; Amigo-Jiménez I; Vituri CL; del Cerro MH; Terol MJ; Albar JP; Rivas G; García-Marco JA; García-Pardo A
J Biol Chem; 2012 Aug; 287(33):27601-13. PubMed ID: 22730324
[TBL] [Abstract][Full Text] [Related]
3. A novel CD44-binding peptide from the pro-matrix metalloproteinase-9 hemopexin domain impairs adhesion and migration of chronic lymphocytic leukemia (CLL) cells.
Ugarte-Berzal E; Bailón E; Amigo-Jiménez I; Albar JP; García-Marco JA; García-Pardo A
J Biol Chem; 2014 May; 289(22):15340-9. PubMed ID: 24739387
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase-9 promotes chronic lymphocytic leukemia b cell survival through its hemopexin domain.
Redondo-Muñoz J; Ugarte-Berzal E; Terol MJ; Van den Steen PE; Hernández del Cerro M; Roderfeld M; Roeb E; Opdenakker G; García-Marco JA; García-Pardo A
Cancer Cell; 2010 Feb; 17(2):160-72. PubMed ID: 20159608
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase-9 is involved in chronic lymphocytic leukemia cell response to fludarabine and arsenic trioxide.
Amigo-Jiménez I; Bailón E; Ugarte-Berzal E; Aguilera-Montilla N; García-Marco JA; García-Pardo A
PLoS One; 2014; 9(6):e99993. PubMed ID: 24956101
[TBL] [Abstract][Full Text] [Related]
6. Targeting the Hemopexin-like Domain of Latent Matrix Metalloproteinase-9 (proMMP-9) with a Small Molecule Inhibitor Prevents the Formation of Focal Adhesion Junctions.
Alford VM; Kamath A; Ren X; Kumar K; Gan Q; Awwa M; Tong M; Seeliger MA; Cao J; Ojima I; Sampson NS
ACS Chem Biol; 2017 Nov; 12(11):2788-2803. PubMed ID: 28945333
[TBL] [Abstract][Full Text] [Related]
7. MMP-9 in B-cell chronic lymphocytic leukemia is up-regulated by alpha4beta1 integrin or CXCR4 engagement via distinct signaling pathways, localizes to podosomes, and is involved in cell invasion and migration.
Redondo-Muñoz J; Escobar-Díaz E; Samaniego R; Terol MJ; García-Marco JA; García-Pardo A
Blood; 2006 Nov; 108(9):3143-51. PubMed ID: 16840734
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of progelatinase B/proMMP-9 affects migration regulatory pathways and impairs chronic lymphocytic leukemia cell homing to bone marrow and spleen.
Bailón E; Ugarte-Berzal E; Amigo-Jiménez I; Van den Steen P; Opdenakker G; García-Marco JA; García-Pardo A
J Leukoc Biol; 2014 Aug; 96(2):185-99. PubMed ID: 25080557
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase-9 induces a pro-angiogenic profile in chronic lymphocytic leukemia cells.
Aguilera-Montilla N; Bailón E; Ugarte-Berzal E; Uceda-Castro R; Prieto-Solano M; García-Martínez E; Samaniego R; Van den Steen PE; Opdenakker G; García-Marco JA; García-Pardo A
Biochem Biophys Res Commun; 2019 Nov; 520(1):198-204. PubMed ID: 31585732
[TBL] [Abstract][Full Text] [Related]
10. MMP-9 affects gene expression in chronic lymphocytic leukemia revealing CD99 as an MMP-9 target and a novel partner in malignant cell migration/arrest.
Aguilera-Montilla N; Bailón E; Uceda-Castro R; Ugarte-Berzal E; Santos A; Gutiérrez-González A; Pérez-Sánchez C; Van den Steen PE; Opdenakker G; García-Marco JA; García-Pardo A
Oncogene; 2019 Jun; 38(23):4605-4619. PubMed ID: 30760844
[TBL] [Abstract][Full Text] [Related]
11. Functional and clinical relevance of CD44 variant isoform expression on B-cell chronic lymphocytic leukemia cells.
Zarcone D; De Rossi G; Tenca C; Marroni P; Mauro FR; Cerruti GM; Albi N; Fiorucci S; Velardi A; Grossi CE
Haematologica; 1998 Dec; 83(12):1088-98. PubMed ID: 9949626
[TBL] [Abstract][Full Text] [Related]
12. In vivo adhesion of malignant B cells to bone marrow microvasculature is regulated by α4β1 cytoplasmic-binding proteins.
Martínez-Moreno M; Leiva M; Aguilera-Montilla N; Sevilla-Movilla S; Isern de Val S; Arellano-Sánchez N; Gutiérrez NC; Maldonado R; Martínez-López J; Buño I; García-Marco JA; Sánchez-Mateos P; Hidalgo A; García-Pardo A; Teixidó J
Leukemia; 2016 Apr; 30(4):861-72. PubMed ID: 26658839
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil elastase cleavage of the gC1q domain impairs the EMILIN1-α4β1 integrin interaction, cell adhesion and anti-proliferative activity.
Maiorani O; Pivetta E; Capuano A; Modica TM; Wassermann B; Bucciotti F; Colombatti A; Doliana R; Spessotto P
Sci Rep; 2017 Jan; 7():39974. PubMed ID: 28074935
[TBL] [Abstract][Full Text] [Related]
14. VEGF/VEGFR2 interaction down-regulates matrix metalloproteinase-9 via STAT1 activation and inhibits B chronic lymphocytic leukemia cell migration.
Ugarte-Berzal E; Redondo-Muñoz J; Eroles P; Del Cerro MH; García-Marco JA; Terol MJ; García-Pardo A
Blood; 2010 Jan; 115(4):846-9. PubMed ID: 19965686
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-9 is up-regulated by CCL21/CCR7 interaction via extracellular signal-regulated kinase-1/2 signaling and is involved in CCL21-driven B-cell chronic lymphocytic leukemia cell invasion and migration.
Redondo-Muñoz J; José Terol M; García-Marco JA; García-Pardo A
Blood; 2008 Jan; 111(1):383-6. PubMed ID: 17890452
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel 82 kDa proMMP-9 species associated with the surface of leukaemic cells: (auto-)catalytic activation and resistance to inhibition by TIMP-1.
Ries C; Pitsch T; Mentele R; Zahler S; Egea V; Nagase H; Jochum M
Biochem J; 2007 Aug; 405(3):547-58. PubMed ID: 17489740
[TBL] [Abstract][Full Text] [Related]
17. Regulation and function of adhesion molecules in B-cell chronic lymphocytic leukaemia.
Jewell AP; Yong KL
Acta Haematol; 1997; 97(1-2):67-72. PubMed ID: 8999721
[TBL] [Abstract][Full Text] [Related]
18. Detection and characterization of human high molecular weight B cell growth factor receptors on leukemic B cells in chronic lymphocytic leukemia.
Uckun FM; Fauci AS; Chandan-Langlie M; Myers DE; Ambrus JL
J Clin Invest; 1989 Nov; 84(5):1595-608. PubMed ID: 2681271
[TBL] [Abstract][Full Text] [Related]
19. Functional and Clinical Significance of the Integrin Alpha Chain CD49d Expression in Chronic Lymphocytic Leukemia.
Dal Bo M; Tissino E; Benedetti D; Caldana C; Bomben R; Poeta GD; Gaidano G; Rossi FM; Bulian P; Zucchetto A; Gattei V
Curr Cancer Drug Targets; 2016; 16(8):659-668. PubMed ID: 27514846
[TBL] [Abstract][Full Text] [Related]
20. Expression of Surface-associated 82 kDa proMMP-9 in Lymphatic Leukemia Blast Cells Differentially Correlates With Prognosis.
Schmohl J; Moebius S; Guenther T; Pepeldjyika E; Seidel CL; Sutanto W; Schuster F; Kraemer D; Salih H; Hartmann A; Tischer J; Ries C; Schmetzer H
Anticancer Res; 2021 Aug; 41(8):3891-3898. PubMed ID: 34281851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
